Related references
Note: Only part of the references are listed.Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model
Anouk E. J. Latenstein et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Upregulation of CD73 Confers Acquired Radioresistance and is Required for Maintaining Irradiation-selected Pancreatic Cancer Cells in a Mesenchymal State
Anna M. Nguyen et al.
MOLECULAR & CELLULAR PROTEOMICS (2020)
Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis
Jeffrey H. Lin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Intraductal Transplantation Models of Human Pancreatic Ductal Adenocarcinoma Reveal Progressive Transition of Molecular Subtypes
Koji Miyabayashi et al.
CANCER DISCOVERY (2020)
Cancer-Associated Fibroblasts Promote the Chemo-resistance in Gastric Cancer through Secreting IL-11 Targeting JAK/STAT3/Bcl2 Pathway
Jun Ma et al.
CANCER RESEARCH AND TREATMENT (2019)
Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxel in patients with previously untreated metastatic pancreatic ductal adenocarcinoma
Kimmie Ng et al.
INVESTIGATIONAL NEW DRUGS (2019)
CanStem111P trial: a Phase III study of napabucasin plus nab-paclitaxel with gemcitabine
Mohamad Bassam Sonbol et al.
FUTURE ONCOLOGY (2019)
Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity
Andrea Padoan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring
Yu Shi et al.
NATURE (2019)
Negative regulators of STAT3 signaling pathway in cancers
Moli Wu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells
Dongfeng Han et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Radiation therapy for pancreatic adenocarcinoma, a treatment option that must be considered in the management of a devastating malignancy
William A. Hall et al.
RADIATION ONCOLOGY (2019)
Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer
Man-Tzu Wang et al.
NATURE COMMUNICATIONS (2019)
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts
Ela Elyada et al.
CANCER DISCOVERY (2019)
Coordination of Immune-Stroma Crosstalk by IL-6 Family Cytokines
Nathaniel R. West
FRONTIERS IN IMMUNOLOGY (2019)
IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer
Olena Kourko et al.
FRONTIERS IN ONCOLOGY (2019)
Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma
Jun W. Kim et al.
NATURE MEDICINE (2019)
Neoadjuvant Therapy for Resectable Pancreatic Cancer: An Evolving Paradigm Shift
Akhil Chawla et al.
FRONTIERS IN ONCOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Impact of combination therapy with anti-PD-1 blockade and a STAT3 inhibitor on the tumor-infiltrating lymphocyte status
Tadashi Ashizawa et al.
IMMUNOLOGY LETTERS (2019)
Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis
Divya Thomas et al.
MOLECULAR CANCER (2019)
Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer
Mitchell L. Ramsey et al.
PANCREATOLOGY (2019)
IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma
Giulia Biffi et al.
CANCER DISCOVERY (2019)
Pathology of pancreatic cancer
Lena Haeberle et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Prashanth Rawla et al.
WORLD JOURNAL OF ONCOLOGY (2019)
Tofacitinib enhances delivery of antibody-based therapeutics to tumor cells through modulation of inflammatory cells
Nathan Simon et al.
JCI INSIGHT (2019)
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
Thomas A. Mace et al.
GUT (2018)
Interleukin-6 Family Cytokines
Stefan Rose-John
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Ruxolitinib plus capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies
Herbert Hurwitz et al.
INVESTIGATIONAL NEW DRUGS (2018)
Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42
Gina L. Razidlo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
A Phase Ib study of ruxolitinib plus gemcitabine ± nab-paclitaxel in patients with advanced solid tumors
Todd M. Bauer et al.
ONCOTARGETS AND THERAPY (2018)
Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
Gwen Lomberk et al.
NATURE COMMUNICATIONS (2018)
Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells
Hai-Bo Xing et al.
BIOMED RESEARCH INTERNATIONAL (2018)
miR-1266 Contributes to Pancreatic Cancer Progression and Chemoresistance by the STAT3 and NF-κB Signaling Pathways
Xin Zhang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Pancreatic Ductal Adenocarcinoma: A Strong imbalance of Good and Bad immunological Cops in the Tumor Microenvironment
Etienne D. Foucher et al.
FRONTIERS IN IMMUNOLOGY (2018)
L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway
Encheng Bai et al.
CANCER MANAGEMENT AND RESEARCH (2018)
STAT3 is a master regulator of epithelial identity and KRAS-driven tumorigenesis
Stephen D'Amico et al.
GENES & DEVELOPMENT (2018)
Phase 1b/2 trial of cancer stemness inhibitor napabucasin (NAPA) plus nab-paclitaxel (nPTX) and gemcitabine (Gem) in metastatic pancreatic adenocarcinoma (mPDAC).
Tanios S. Bekaii-Saab et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The molecular details of cytokine signaling via the JAK/STAT pathway
Rhiannon Morris et al.
PROTEIN SCIENCE (2018)
Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer
Lanyun Feng et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
Andrew McGuigan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
Christian Bressy et al.
CANCER RESEARCH (2018)
Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotype
Mirna Swayden et al.
HELIYON (2018)
Do STAT3 inhibitors have potential in the future for cancer therapy?
Andrea L. A. Wong et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
IL-6 roles - Molecular pathway and clinical implication in pancreatic cancer - A systemic review
Vlad-Vasile Pop et al.
IMMUNOLOGY LETTERS (2017)
Early detection of pancreatic cancer: Where are we now and where are we going?
Bin Zhou et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Regulation of EMT by STAT3 in gastrointestinal cancer (Review)
Bo Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
High Dose Adaptive MRI Guided Radiation Therapy Improves Overall Survival of Inoperable Pancreatic Cancer
S. Rudra et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Daniel Ohlund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Dual Roles of IL-27 in Cancer Biology and Immunotherapy
Marina Fabbi et al.
MEDIATORS OF INFLAMMATION (2017)
Serum interleukin-6 is associated with pancreatic ductal adenocarcinoma progression pattern
Hyoung Woo Kim et al.
MEDICINE (2017)
Tumor-related interleukins: old validated targets for new anti-cancer drug development
Sarra Setrerrahmane et al.
MOLECULAR CANCER (2017)
Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer
Jacob M. Smigiel et al.
MOLECULAR CANCER RESEARCH (2017)
Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling
D. J. Junk et al.
ONCOGENE (2017)
Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters
Patricia Dauer et al.
PANCREATOLOGY (2017)
Pancreatic cancer stroma: controversies and current insights
Daniel Ansari et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
miR-1181 inhibits invasion and proliferation via STAT3 in pancreatic cancer
Jie Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
The antiangiogenic role of the pro-inflammatory cytokine interleukin-31
Shiri Davidi et al.
ONCOTARGET (2017)
Inhibition of Jak/STAT signaling reduces the activation of pancreatic stellate cells in vitro and limits caerulein-induced chronic pancreatitis in vivo
Hannah M. Komar et al.
SCIENTIFIC REPORTS (2017)
Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT Inhibitors
Lisa N. Heppler et al.
TRENDS IN CANCER (2017)
Effect of palliative surgery chemotherapy, and radiation in stage IV pancreatic cancer.
Brooke Vuong et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going
Chen Liang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Andrew J. Aguirre et al.
CANCER CELL (2017)
Interleukin-27 inhibits malignant behaviors of pancreatic cancer cells by targeting M2 polarized tumor associated macrophages
Lutian Yao et al.
CYTOKINE (2017)
Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells
Yuan Seng Wu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Enzyme-mediated stiffening hydrogels for probing activation of pancreatic stellate cells
Hung-Yi Liu et al.
ACTA BIOMATERIALIA (2017)
Systemic Immune Activity Predicts Overall Survival in Treatment-Naive Patients with Metastatic Pancreatic Cancer
Matthew R. Farren et al.
CLINICAL CANCER RESEARCH (2016)
STAT3 integrates cooperative Ras and TGF-β signals that induce Snail expression
M. Saitoh et al.
ONCOGENE (2016)
More deaths from pancreatic cancer than breast cancer in the EU by 2017
J. Ferlay et al.
ACTA ONCOLOGICA (2016)
Serum interleukin-6 as a prognostic biomarker for survival in patients with unresectable pancreatic cancer
I. Chen et al.
ANNALS OF ONCOLOGY (2016)
FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling
Xuguang Yang et al.
CANCER RESEARCH (2016)
Changing the course of pancreatic cancer - Focus on recent translational advances
Milind Jayle et al.
CANCER TREATMENT REVIEWS (2016)
Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity
Thomas R. Flint et al.
CELL METABOLISM (2016)
IL-6/STAT3 Plays a Regulatory Role in the Interaction Between Pancreatic Stellate Cells and Cancer Cells
Shin Hamada et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival
Sonja M. Woermann et al.
GASTROENTEROLOGY (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Regulation of pancreatic cancer aggressiveness by stromal stiffening
Nicola Rath et al.
NATURE MEDICINE (2016)
Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression
Hanane Laklai et al.
NATURE MEDICINE (2016)
Leukemia inhibitory factor receptor negatively regulates the metastasis of pancreatic cancer cells in vitro and in vivo
Ding Ma et al.
ONCOLOGY REPORTS (2016)
Key players in pancreatic cancer-stroma interaction: cancer-associated fibroblasts, endothelial and inflammatory cells
Michael Friberg Bruun Nielsen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis
Pin Wu et al.
ONCOTARGET (2016)
Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling
Xiaoqing Wu et al.
ONCOTARGET (2016)
Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells
Nagaraj S. Nagathihalli et al.
ONCOTARGET (2016)
Proteolytic Cleavage Governs Interleukin-11 Trans-signaling
Juliane Lokau et al.
CELL REPORTS (2016)
Projections of cancer incidence and cancer-related deaths inGermany by 2020 and 2030
Anne S. Quante et al.
CANCER MEDICINE (2016)
Neoadjuvant radiotherapeutic strategies in pancreatic cancer
Falk Roeder
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs
Jordan Anaya
PEERJ COMPUTER SCIENCE (2016)
Pancreatic stellate cell: physiologic role, role in fibrosis and cancer
Minote Apte et al.
CURRENT OPINION IN GASTROENTEROLOGY (2015)
Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer
Cameron N. Johnstone et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer
Nagaraj S. Nagathihalli et al.
GASTROENTEROLOGY (2015)
Stromal biology and therapy in pancreatic cancer: a changing paradigm
Albrecht Neesse et al.
GUT (2015)
IL-11 signaling as a therapeutic target for cancer
Tracy L. Putoczki et al.
IMMUNOTHERAPY (2015)
Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer
Freya A. Goumas et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
Herbert I. Hurwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model
Estanislao Nistal-Villan et al.
MOLECULAR CANCER (2015)
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell et al.
NATURE (2015)
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A. Moffitt et al.
NATURE GENETICS (2015)
Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels
Tomofumi Miura et al.
PANCREAS (2015)
The role of pancreatic stellate cells in pancreatic cancer
John A. G. Moir et al.
SURGICAL ONCOLOGY-OXFORD (2015)
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K. Witkiewicz et al.
NATURE COMMUNICATIONS (2015)
Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells
Hui Zhang et al.
ONCOTARGET (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression
Vindhya Palagani et al.
CARCINOGENESIS (2014)
Molecular Pathways: IL11 as a Tumor-Promoting Cytokine-Translational Implications for Cancers
Matthias Ernst et al.
CLINICAL CANCER RESEARCH (2014)
Reconstruction of an active SOCS3-based E3 ubiquitin ligase complex in vitro: identification of the active components and JAK2 and gp130 as substrates
Nadia J. Kershaw et al.
GROWTH FACTORS (2014)
Interleukin-6: a villain in the drama of pancreatic cancer development and progression
Reinhild Holmer et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2014)
Pancreatic Cancer-Induced Cachexia Is Jak2-Dependent in Mice
Marine Gilabert et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348)
T. Zhou et al.
LEUKEMIA (2014)
Pancreatic Adenocarcinoma
David P. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Serum Cytokine Profile in Patients With Pancreatic Cancer
Carolina Torres et al.
PANCREAS (2014)
Evidence for the Importance of Personalized Molecular Profiling in Pancreatic Cancer
Loukia N. Lili et al.
PANCREAS (2014)
Selected Cytokines in Patients with Pancreatic Cancer: A Preliminary Report
Wojciech Blogowski et al.
PLOS ONE (2014)
Interleukin-6 in inflammatory and malignant diseases of the pancreas
Marina Lesina et al.
SEMINARS IN IMMUNOLOGY (2014)
Plasma interleukin-11 (IL-11) levels have diagnostic and prognostic roles in patients with pancreatic cancer
Chuanli Ren et al.
TUMOR BIOLOGY (2014)
Chronic Inflammation and Cytokines in the Tumor Microenvironment
Glauben Landskron et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
STAT3 Target Genes Relevant to Human Cancers
Richard L. Carpenter et al.
CANCERS (2014)
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu et al.
NATURE REVIEWS CANCER (2014)
Interleukin-11 Is the Dominant IL-6 Family Cytokine during Gastrointestinal Tumorigenesis and Can Be Targeted Therapeutically
Tracy L. Putoczki et al.
CANCER CELL (2013)
Pancreatic Cancer-Associated Stellate Cells Promote Differentiation of Myeloid-Derived Suppressor Cells in a STAT3-Dependent Manner
Thomas A. Mace et al.
CANCER RESEARCH (2013)
Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance
Yaqing Zhang et al.
CANCER RESEARCH (2013)
Complete Remission Achieved With Single Agent CNTO 328, an Anti-IL-6 Monoclonal Antibody, in Relapsed and Refractory Myeloma
Ajai Chari et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
Inflammatory networks and immune surveillance of pancreatic carcinoma
Robert H. Vonderheide et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Control of Cell Identity in Pancreas Development and Regeneration
Ben Z. Stanger et al.
GASTROENTEROLOGY (2013)
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Michael A. Jacobetz et al.
GUT (2013)
Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma
Dong Tang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Randomized phase III study of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic adenocarcinoma of the pancreas (MPACT)
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Activation of the IL-6R/Jak/Stat Pathway is Associated with a Poor Outcome in Resected Pancreatic Ductal Adenocarcinoma
Simon M. Denley et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
Understanding the stroma of pancreatic cancer: co-evolution of the microenvironment with epithelial carcinogenesis
Mert Erkan
JOURNAL OF PATHOLOGY (2013)
SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition
Nadia J. Kershaw et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Activation state of stromal inflammatory cells in murine metastatic pancreatic adenocarcinoma
Douglas D. Benson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2012)
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
Paolo P. Provenzano et al.
CANCER CELL (2012)
Identification of Sox9-Dependent Acinar-to-Ductal Reprogramming as the Principal Mechanism for Initiation of Pancreatic Ductal Adenocarcinoma
Janel L. Kopp et al.
CANCER CELL (2012)
Transcriptional regulation of the interleukin-11 gene by oncogenic Ras
Soon Young Shin et al.
CARCINOGENESIS (2012)
Clinical Significance of the Genetic Landscape of Pancreatic Cancer and Implications for Identification of Potential Longterm Survivors
Shinichi Yachida et al.
CLINICAL CANCER RESEARCH (2012)
Therapeutic Potential of Perineural Invasion, Hypoxia and Desmoplasia in Pancreatic Cancer
Han Liu et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Interleukin-6 signalling: More than Jaks and STATs
Rene Eulenfeld et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2012)
Signaling by IL-31 and functional consequences
Christian Cornelissen et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2012)
Suppression of Cytokine Signaling by SOCS3: Characterization of the Mode of Inhibition and the Basis of Its Specificity
Jeffrey J. Babon et al.
IMMUNITY (2012)
The role of stroma in pancreatic cancer: diagnostic and therapeutic implications
Mert Erkan et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment
Bin Bao et al.
PLOS ONE (2012)
Interleukin-8, a promising predictor for prognosis of pancreatic cancer
Ying Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Cardiotrophin-1 determines liver engraftment of syngenic colon carcinoma cells through an immune system-mediated mechanism
Matilde Bustos et al.
ONCOIMMUNOLOGY (2012)
Current knowledge on pancreatic cancer
Juan Iovanne et al.
FRONTIERS IN ONCOLOGY (2012)
Pancreatitis-Induced Inflammation Contributes to Pancreatic Cancer by Inhibiting Oncogene-Induced Senescence
Carmen Guerra et al.
CANCER CELL (2011)
Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression
Akihisa Fukuda et al.
CANCER CELL (2011)
Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer
Marina Lesina et al.
CANCER CELL (2011)
STAT3 Plays a Critical Role in KRAS-Induced Pancreatic Tumorigenesis
Ryan B. Corcoran et al.
CANCER RESEARCH (2011)
Cooperative Signaling between Oncostatin M, Hepatocyte Growth Factor and Transforming Growth Factor-beta Enhances Epithelial to Mesenchymal Transition in Lung and Pancreatic Tumor Models
Gretchen M. Argast et al.
CELLS TISSUES ORGANS (2011)
Mast Cells in Tumor Microenvironment Promotes the In Vivo Growth of Pancreatic Ductal Adenocarcinoma
David Z. Chang et al.
CLINICAL CANCER RESEARCH (2011)
Stromal biology and therapy in pancreatic cancer
Albrecht Neesse et al.
GUT (2011)
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Simon A. Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro
C. Huang et al.
NEOPLASMA (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Targeting STAT3 Signaling in Pancreatic Cancer Promotes Antiapoptotic Gene Expression
Wolfgang Glienke et al.
PANCREAS (2011)
STAT3 Knockdown Reduces Pancreatic Cancer Cell Invasiveness and Matrix Metalloproteinase-7 Expression in Nude Mice
Hai Dong Li et al.
PLOS ONE (2011)
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Gregory L. Beatty et al.
SCIENCE (2011)
Role of Pancreatic Stellate Cells in Pancreatic Cancer Metastasis
Zhihong Xu et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
J-F Rossi et al.
BRITISH JOURNAL OF CANCER (2010)
Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
Li Lin et al.
CANCER RESEARCH (2010)
Hallmarks of cancer: Interactions with the tumor stroma
Kristian Pietras et al.
EXPERIMENTAL CELL RESEARCH (2010)
Diagnostic Usefulness of Serum Interleukin 6 (IL-6) and C-Reactive Protein (CRP) in the Differentiation Between Pancreatic Cancer and Chronic Pancreatitis
Barbara Mroczko et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2010)
Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro
Chen Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Richard E. Royal et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Structural Biology of Shared Cytokine Receptors
Xinquan Wang et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Context-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-Ras
Sharon Y. Gidekel Friedlander et al.
CANCER CELL (2009)
Unique Methylation Pattern of Oncostatin M Receptor Gene in Cancers of Colorectum and Other Digestive Organs
Guoren Deng et al.
CLINICAL CANCER RESEARCH (2009)
Desmoplasia of Pancreatic Ductal Adenocarcinoma
Stephen Pandol et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Roles of Pancreatic Stellate Cells in Pancreatic Inflammation and Fibrosis
Atsushi Masamune et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Inflammation and pancreatic cancer: an evidence-based review
Julia B. Greer et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Clinical Significance of Interleukin-6 (Il-6) Gene Polymorphism and Il-6 Serum Level in Pancreatic Adenocarcinoma and Chronic Pancreatitis
Renata Talar-Wojnarowska et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma
A. Van den Broeck et al.
EJSO (2009)
The SOCS Box Encodes a Hierarchy of Affinities for Cullin5: Implications for Ubiquitin Ligase Formation and Cytokine Signalling Suppression
Jeffrey J. Babon et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma - Is cure possible?
Thomas Schnelldorfer et al.
ANNALS OF SURGERY (2008)
Pancreatic stellate cells: Partners in crime with pancreatic cancer cells
Alain Vonlaufen et al.
CANCER RESEARCH (2008)
Cancer-associated stroma fibroblasts promote pancreatic tumor progression
Rosa F. Hwang et al.
CANCER RESEARCH (2008)
Structures and biological functions of IL-31 and IL-31 receptors
Qing Zhang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Mesothelin targeted cancer immunotherapy
Raffit Hassan et al.
EUROPEAN JOURNAL OF CANCER (2008)
The SOCS box domain of SOCS3: Structure and interaction with the elonginBC-cullin5 ubiquitin ligase
Jeffrey J. Babon et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
The role of the tumor microenvironment in the progression of pancreatic cancer
Buckminster Farrow et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia
De La O. Jean-Paul et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice
Nils Habbe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis
Brooke Ancrile et al.
GENES & DEVELOPMENT (2007)
IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells
Louis W. Feurino et al.
CANCER BIOLOGY & THERAPY (2007)
Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation
Uddalak Bharadwaj et al.
CANCER RESEARCH (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The dynamics of signal triggering in a gp130-receptor complex
Rishi Matadeen et al.
STRUCTURE (2007)
Identification of pancreatic cancer stem cells
Chenwei Li et al.
CANCER RESEARCH (2007)
Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro
Chen Huang et al.
CANCER SCIENCE (2006)
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival
G Bellone et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Phylogeny and evolution of class-I helical cytokines
MO Huising et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia
ME Martignoni et al.
CLINICAL CANCER RESEARCH (2005)
Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells
M Ishikawa et al.
CANCER SCIENCE (2005)
Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia
D Segara et al.
CLINICAL CANCER RESEARCH (2005)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells
MG Bachem et al.
GASTROENTEROLOGY (2005)
Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor
D Derouet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27
S Pflanz et al.
JOURNAL OF IMMUNOLOGY (2004)
An illustrated consensus on the classification of pancreatic Intraepithelial neoplasia and intraductal papillary mucinous neoplasms
RH Hruban et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Cytokines in pancreatic carcinoma - Correlation with phenotypic characteristics and prognosis
B Ebrahimi et al.
CANCER (2004)
New IL-6 (gp130) family cytokine members, CLC/NNT1/BSF3 and IL-27
M Murakami et al.
GROWTH FACTORS (2004)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer
A Scholz et al.
GASTROENTEROLOGY (2003)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
Role of stromal-derived cytokines and growth factors in bone metastasis
GD Roodman
CANCER (2003)
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis
DY Wei et al.
ONCOGENE (2003)
SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130
U Lehmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo
JG Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2
S Kamizono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses
T Jostock et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Interleukin-11 signals through the formation of a hexameric receptor complex
VA Barton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: Structural receptor requirements for signal attenuation
D Anhuf et al.
JOURNAL OF IMMUNOLOGY (2000)
Cytokines and advanced cancer
RJ Dunlop et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2000)
Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130
SE Nicholson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130
J Schmitz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The cytoplasmic tyrosine motifs is full-length glycoprotein 130 have different roles in IL-6 signal transduction
J Schmitz et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
